Genomic alterations and clinical outcomes in patients with dedifferentiated liposarcoma-Reference-Cited by-同舟云学术

Genomic alterations and clinical outcomes in patients with dedifferentiated liposarcoma

Published:2022-12-04 Issue:6 Volume:12 Page:7029-7038
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Jagosky Megan H.¹,Anderson Colin J.²,Symanowski James T.³,Steuerwald Nury M.⁴,Farhangfar Carol J.⁵,Baldrige Emily A.⁶,Benbow Jennifer H.⁷,Livingston Michael B.¹,Patt Joshua C.²,Ahrens Will A.⁸,Kneisl Jeffrey S.²,Kim Edward S.⁷

Affiliation:

1. Department of Solid Tumor Oncology, Levine Cancer Institute, Carolinas Medical Center, Atrium Health Charlotte North Carolina USA

2. Department of Orthopedic Oncology, Musculoskeletal Institute, Atrium Health Charlotte North Carolina USA

3. Department of Biostatistics, Levine Cancer Institute, Carolinas Medical Center Atrium Health Charlotte North Carolina USA

4. The Molecular Biology and Genomics Laboratory, Levine Cancer Institute, Carolinas Medical Center, Atrium Health Charlotte North Carolina USA

5. LCI Translational Research, Levine Cancer Institute, Carolinas Medical Center, Atrium Health Charlotte North Carolina USA

6. LCI Research Support, Clinical Trials Office, Levine Cancer Institute, Carolinas Medical Center, Atrium Health Charlotte North Carolina USA

7. City of Hope Comprehensive Cancer Center Duarte California USA

8. Department of Pathology Levine Cancer Institute, Carolinas Medical Center, Atrium Health Charlotte North Carolina USA

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.5502

Reference42 articles.

1. Histologic Subtype and Margin of Resection Predict Pattern of Recurrence and Survival for Retroperitoneal Liposarcoma

2. MDM2-Dependent Rewiring of Metabolomic and Lipidomic Profiles in Dedifferentiated Liposarcoma Models

3. Differential sensitivity of liposarcoma subtypes to chemotherapy

4. Doxorubicin‐based chemotherapy for the palliative treatment of adult patients with locally advanced or metastatic soft tissue sarcoma;Bramwell VH;Cochrane Database Syst Rev,2003

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive Analysis of a Six-Gene Signature Predicting Survival and Immune Infiltration of Liposarcoma Patients and Deciphering Its Therapeutic Significance;International Journal of Molecular Sciences;2024-07-16

2. HER3 (ERBB3) amplification in liposarcoma - a putative new therapeutic target?;World Journal of Surgical Oncology;2024-05-17